- Reuters
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/19/2024 | $211.00 → $202.00 | Neutral | MoffettNathanson | |
| 11/6/2024 | $170.00 | Mkt Perform → Outperform | Raymond James | |
| 11/4/2024 | $300.00 → $275.00 | Buy | Loop Capital | |
| 11/1/2024 | $203.00 → $215.00 | Hold | Maxim Group | |
| 10/25/2024 | $200.00 | Sector Weight → Underweight | KeyBanc Capital Markets | |
| 10/7/2024 | $205.00 → $212.92 | Buy → Hold | Jefferies | |
| 8/19/2024 | $211.00 | Neutral | MoffettNathanson | |
| 8/2/2024 | $195.00 → $203.00 | Hold | Maxim Group |
Masimo (NASDAQ:MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ:MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers &
News and outlook: In October 2024, Artprice by Artmarket has reached a new milestone with its Intuitive Artmarket® AI and its positive impact on annual recurring revenue growth. PARIS, Nov. 14, 2024 /PRNewswire/ -- In mid-October 2024, Artprice by Artmarket began providing data trained by its proprietary artificial intelligence (Intuitive Artmarket®) to its high-end subscribers. Rather than imposing on its 9.3 million customers and members a radical transformation of its databases, which have been the reference in the art world for 27 years, Artprice by Artmarket has judiciously decided to gradually inject proprietary data from its AI into its Artprice databases, without it being specified
Intelligent new features, timesaving tools, and new creative options come to Final Cut Pro across Mac, iPad, and iPhone, plus editing for spatial video Apple® today unveiled Final Cut Pro® 11 — supercharged with intelligent new features — along with powerful updates to Final Cut Pro for iPad®, Final Cut Camera™, and Logic Pro®. Offering new tools like Magnetic Mask and the highly anticipated Transcribe to Captions, Final Cut Pro 11 for Mac®1 also supports the import, edit, and delivery of spatial video projects directly to Apple Vision Pro™.2 Final Cut Pro for iPad 2.1 advances the touch-first editing experience with support for Enhance Light and Color; new Live Drawing inks; haptic fee
4 - Apple Inc. (0000320193) (Issuer)
4 - Apple Inc. (0000320193) (Issuer)
4 - MASIMO CORP (0000937556) (Issuer)
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board Masimo Corporation (NASDAQ:MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the "Board"), effective immediately. Following these appointments, the Board will consist of eight directors. Quentin Koffey, Lead Independent Director of Masimo, stated, "We are pleased to welcome Tim and Wendy as our newest independent directors. Both are high-caliber professionals who will bring critical perspectives to the Board and possess expertise that closely aligns
Appoints Michelle Brennan as Interim CEO Following Joe Kiani's Decision to Resign Continues to Be Committed to Review of Strategic Alternatives for Consumer Businesses, With Assistance From Leading Financial and Legal Advisors Reaffirms Financial Guidance for Third Quarter 2024 Today the Board of Directors (the "Board") of Masimo (NASDAQ:MASI) a leading global medical innovator, provided a series of leadership and business updates: Leadership Appointments Michelle Brennan, a current member of Masimo's Board, has been appointed interim Chief Executive Officer ("CEO") following Chairman and CEO Joe Kiani informing the Board of his decision to resign as CEO. After being elected by shareho
Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m
MoffettNathanson reiterated coverage of Apple with a rating of Neutral and set a new price target of $202.00 from $211.00 previously
Raymond James upgraded Masimo from Mkt Perform to Outperform and set a new price target of $170.00
Loop Capital reiterated coverage of Apple with a rating of Buy and set a new price target of $275.00 from $300.00 previously
8-K - MASIMO CORP (0000937556) (Filer)
8-K - MASIMO CORP (0000937556) (Filer)
10-Q - MASIMO CORP (0000937556) (Filer)
SC 13D/A - MASIMO CORP (0000937556) (Subject)
SC 13D/A - MASIMO CORP (0000937556) (Subject)
SC 13D/A - MASIMO CORP (0000937556) (Subject)
To gain an edge, this is what you need to know today. GDP Brings Buying Please click here for an enlarged chart of Invesco QQQ Trust Series 1 (NASDAQ:QQQ). Note the following: The chart shows a drop in QQQ. The drop in QQQ was triggered by speculative sentiment pulling back. As a reader of The Arora Report, you knew in advance that speculative sentiment could fall as a result of Tesla Inc (NASDAQ:TSLA) earnings. The chart shows that QQQ is approaching the support zone. RSI on the chart shows that QQQ is now oversold. Oversold markets tend to bounce. The chart shows that the volume was low on the selloff. This indicates a lack of conviction in selling. Especially hard hit in
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Baird increased Apple Inc. (NASDAQ:AAPL) price target from $200 to $240. Baird analyst William Power maintained an Outperform rating. Apple shares fell 0.1% to trade at $218.51 on Thursday. See how other analysts view this stock. Truist Securities raised the price target for ServiceNow, Inc. (NYSE:NOW) from $750 to $780. Truist Securities analyst Joel Fishbein maintained a Hold rating. ServiceNow shares gained 11.9% to trade at $817.75 on Thursday. See how other analysts view this stock. JP Morg
"Hedging Is Gaining Traction" That's what Goldman Sachs's flow of funds guru Scott Rubner said in his note earlier today ("I Am Not Buying This Dip"). He also pointed out that four of the Magnificent Seven mega caps are reporting earnings next week: Microsoft Corporation (NASDAQ:MSFT), Meta Platforms, Inc. (NASDAQ:META), Apple, Inc. (NASDAQ:AAPL), and Amazon.com, Inc. (NASDAQ:AMZN), and that if their results and guidance are not "great", those stocks will likely get punished in this market environment. In the video below, I show inexpensive ways of hedging Microsoft and Meta ahead of their earnings next week. I mention a couple of times there that there's a link to download the newly
Third Quarter 2024 Highlights: Healthcare revenue of $343.3 million increased 11.5% on a reported basis and 11.7% on a constant currency basis(1); GAAP net income per diluted share was $0.18; and Non-GAAP(1) net income per diluted share was $0.98. Masimo Corporation (NASDAQ:MASI) today announced its financial results for the third quarter ended September 28, 2024. Third Quarter 2024 Results Consolidated revenue was $504.6 million, comprised of healthcare revenue of $343.3 million and non-healthcare revenue of $161.3 million. Shipments of noninvasive technology boards and instruments were 60,500. GAAP operating income was $30.1 million and non-GAAP(1) operating income was $80.8
iPhone drives record September quarter revenue Services revenue reaches new all-time high Apple® today announced financial results for its fiscal 2024 fourth quarter ended September 28, 2024. The Company posted quarterly revenue of $94.9 billion, up 6 percent year over year, and quarterly diluted earnings per share of $0.97. Diluted earnings per share was $1.64,1 up 12 percent year over year when excluding the one-time charge recognized during the fourth quarter of 2024 related to the impact of the reversal of the European General Court's State Aid decision. "Today Apple is reporting a new September quarter revenue record of $94.9 billion, up 6 percent from a year ago," said Tim Cook, Ap
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ:MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Michelle Brennan, interim Chief Executive Officer, Micah Young, Executive Vice President and Chief Financial Officer and Bilal Muhsin, Chief Operating Officer. To register for the conference call and receive the dial-in number, please use the link below. Upon registering, each participant will be provided with details including the dial-in number and a re
For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a
For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea